Literature DB >> 1349532

Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor.

D G Jackson1, D N Hart, G Starling, J I Bell.   

Abstract

The CMRF35 monoclonal antibody recognizes a cell membrane antigen present on the surface of monocytes, neutrophils, a proportion of peripheral blood T and B lymphocytes and lymphocytic cell lines. Initial studies with CMRF35 suggested an unusual pattern of serological reactivity which did not correspond to any of the known leukocyte differentiation antigen clusters. We describe here the cloning and sequencing of a cDNA encoding the CMRF35 antigen by means of expression in COS cells and immunoselection with the CMRF35 monoclonal antibody. The cDNA encodes a novel integral membrane glycoprotein of 224 amino acids that represents a new member of the immunoglobulin (Ig) gene superfamily. The molecule comprises (a) a single extracellular Ig variable domain remarkably similar to the Fc receptor for polymeric IgA and IgM, (b) a membrane-proximal domain containing a high proportion of proline, serine and threonine residues that was predicted to be heavily O-glycosylated, (c) an unusual transmembrane anchor that contained a glutamic acid and a proline residue and (d) a short cytoplasmic tail. Transcripts encoding the CMRF35 protein were detected in early monocytic cell lines, in peripheral blood T cells and in some B lymphoblastoid cell lines, confirming the results of immunocytological staining. However, the level of CMRF35 expression on peripheral blood T cells was shown to decrease in response to mitogenic stimulation. The likelihood that the CMRF35 antigen shares a common evolutionary ancestor with the poly Ig Fc receptor is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349532     DOI: 10.1002/eji.1830220508

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation.

Authors:  Agueda Martínez-Barriocanal; Emma Comas-Casellas; Simo Schwartz; Margarita Martín; Joan Sayós
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

2.  Ancient divergence of a complex family of immune-type receptor genes.

Authors:  John P Cannon; Robert N Haire; M Gail Mueller; Ronda T Litman; Donna D Eason; Deborah Tinnemore; Chris T Amemiya; Tatsuya Ota; Gary W Litman
Journal:  Immunogenetics       Date:  2006-04-26       Impact factor: 2.846

3.  Channel catfish leukocyte immune-type receptors contain a putative MHC class I binding site.

Authors:  James L Stafford; Eva Bengtén; Louis Du Pasquier; Norman W Miller; Melanie Wilson
Journal:  Immunogenetics       Date:  2006-12-06       Impact factor: 2.846

4.  CD300c is an activating receptor expressed on human monocytes.

Authors:  Venkateswara R Simhadri; John L Mariano; Aleksandra Gil-Krzewska; Qing Zhou; Francisco Borrego
Journal:  J Innate Immun       Date:  2013-04-06       Impact factor: 7.349

5.  Expression of the CMRF-35 antigen, a new member of the immunoglobulin gene superfamily, is differentially regulated on leucocytes.

Authors:  A Daish; G C Starling; J L McKenzie; J C Nimmo; D G Jackson; D N Hart
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

6.  NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.

Authors:  C Cantoni; C Bottino; M Vitale; A Pessino; R Augugliaro; A Malaspina; S Parolini; L Moretta; A Moretta; R Biassoni
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

7.  Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow.

Authors:  Eiji Umemoto; Toshiyuki Tanaka; Hidenobu Kanda; Soojung Jin; Kazuo Tohya; Kazuhiro Otani; Takahiro Matsutani; Masanori Matsumoto; Yukihiko Ebisuno; Myoung Ho Jang; Minoru Fukuda; Takako Hirata; Masayuki Miyasaka
Journal:  J Exp Med       Date:  2006-06-05       Impact factor: 14.307

8.  A CD300c-Fc Fusion Protein Inhibits T Cell Immunity.

Authors:  Cheng Cui; Min Su; Yujun Lin; Laijun Lai
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.